|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 63.54 USD | -0.44% |
|
-1.50% | -11.79% |
| Capitalization | 9.94B 8.53B 7.97B 7.45B 13.87B 893B 15.02B 93.55B 36.1B 422B 37.32B 36.53B 1,539B | P/E ratio 2026 * |
49.7x | P/E ratio 2027 * | 43.1x |
|---|---|---|---|---|---|
| Enterprise value | 9.89B 8.48B 7.93B 7.4B 13.79B 888B 14.94B 93.02B 35.89B 420B 37.11B 36.32B 1,530B | EV / Sales 2026 * |
8.07x | EV / Sales 2027 * | 7.3x |
| Free-Float |
99.46% | Yield 2026 * |
0.5% | Yield 2027 * | 0.5% |
Last Transcript: Bio-Techne Corporation
| 1 day | -0.44% | ||
| 1 week | -1.50% | ||
| Current month | -1.50% | ||
| 1 month | +3.99% | ||
| 3 months | +20.07% | ||
| 6 months | +27.46% | ||
| Current year | -11.79% |
| 1 week | 61.27 |  | 65.25 |
| 1 month | 54.2 | | 66.06 |
| Current year | 46.01 | | 79.28 |
| 1 year | 46.01 | | 79.28 |
| 3 years | 46.01 | | 89.91 |
| 5 years | 46.01 | | 135.96 |
| 10 years | 19.99 | | 135.96 |
| Manager | Title | Age | Since |
|---|---|---|---|
Kim Kelderman
CEO | Chief Executive Officer | 58 | 2024-01-31 |
James Hippel
DFI | Director of Finance/CFO | 54 | 2014-03-31 |
David Clair
IRC | Investor Relations Contact | - | 2019-09-30 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 69 | 2012-11-01 | |
John Higgins
BRD | Director/Board Member | 55 | 2009-05-18 |
Alpna Seth
BRD | Director/Board Member | 62 | 2017-10-25 |
| Name | Weight | AuM | Varia. Jan 1. | Investor |
|---|---|---|---|---|
 | 2.93% | 1 M€ | 0.00% | - |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -0.44% | -1.50% | -16.27% | -23.08% | 9.94B | |
| -0.94% | +1.37% | +4.46% | +8.81% | 48.57B | |
| -1.02% | -2.21% | +10.71% | +6.13% | 38.7B | |
| -1.91% | -2.70% | +66.46% | +75.61% | 37.39B | |
| -0.38% | -2.56% | +6.69% | +19.18% | 27.39B | |
| -5.50% | -8.05% | +57.31% | +165.09% | 16.24B | |
| +1.02% | +0.93% | +62.65% | +222.70% | 15.02B | |
| -1.07% | +0.42% | -13.39% | -9.27% | 14.34B | |
| -0.04% | -1.11% | +120.22% | +109.88% | 13.26B | |
| +1.90% | -2.05% | +31.63% | - | 13.33B | |
| Average | -0.79% | -0.99% | +33.04% | +63.89% | 23.42B | |
| Weighted average by Cap. | -0.97% | -0.64% | +29.17% | +50.43% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 1.22B 1.05B 982M 917M 1.71B 110B 1.85B 11.52B 4.45B 51.97B 4.6B 4.5B 189B | 1.31B 1.12B 1.05B 980M 1.83B 118B 1.98B 12.31B 4.75B 55.55B 4.91B 4.81B 203B |
| Net income | 202M 173M 162M 151M 281M 18.1B 304M 1.9B 732M 8.55B 756M 740M 31.19B | 235M 202M 189M 176M 328M 21.14B 355M 2.21B 854M 9.99B 883M 864M 36.42B |
| Net Debt | -57.07M -48.94M -45.77M -42.74M -79.59M -5.13B -86.21M -537M -207M -2.42B -214M -210M -8.83B | -390M -334M -313M -292M -543M -35.01B -589M -3.67B -1.41B -16.54B -1.46B -1.43B -60.31B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 25-12-04 | 63.54 $ | -0.44% | 1,421,519 |
| 25-12-03 | 63.82 $ | +1.38% | 1,783,107 |
| 25-12-02 | 62.95 $ | -1.27% | 1,368,627 |
| 25-12-01 | 63.76 $ | -1.16% | 1,657,014 |
| 25-11-28 | 64.51 $ | -0.19% | 867,038 |
Delayed Quote Nasdaq, December 04, 2025 at 04:00 pm
More quotes
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- TECH Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition